Common errors in forensic pediatric pathology

W Q Sturner1

  • 1Arkansas State Crime Laboratory, Little Rock 72215, USA.

Insights

Pediatric medicolegal autopsies require careful attention due to unique challenges in infants and children. This review identifies ten error categories to improve accuracy in forensic pediatric death investigations.

Area of Science:

  • Forensic Pathology
  • Pediatric Autopsy
  • Medicolegal Death Investigation

Background:

  • Medicolegal autopsies in children are performed with some frequency.
  • While errors in adult forensic autopsies have been discussed, a comparable analysis for pediatric cases is lacking.
  • Professor Alan Moritz's work on adult autopsy errors is a foundational reference.

Purpose of the Study:

  • To identify and categorize potential and actual errors specific to pediatric medicolegal autopsies.
  • To provide a framework for minimizing mistakes in infant and child forensic examinations.
  • To address the unique challenges presented by the smaller size and developmental stage of pediatric subjects.

Main Methods:

  • Review of literature and case analyses pertaining to pediatric medicolegal autopsies.
  • Identification and categorization of ten distinct types of errors.
  • Comparison of pediatric autopsy challenges with those identified in adult forensic examinations.

Main Results:

  • Ten categories of potential and actual errors in pediatric medicolegal autopsies have been identified.
  • Some identified errors are analogous to those found in adult autopsies.
  • Unique challenges in pediatric cases stem from anatomical size and developmental differences, increasing the risk of observational and interpretative errors.

Conclusions:

  • Thorough documentation of all findings is crucial for accurate pediatric medicolegal autopsies.
  • Proper evidence collection, storage, and access to comprehensive data (scene, medical records, lab results) are essential.
  • Adherence to best practices in pediatric forensic autopsy can significantly reduce errors of omission and commission.

Related Concept Videos

Systematic Error: Methodological and Sampling Errors01:15

Systematic Error: Methodological and Sampling Errors

In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...